Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.6050
-0.0201 (-3.22%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Incannex Healthcare Employees
Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.
Employees
9
Change
6
Growth
200.00%
Revenue / Employee
$10,889
Profits / Employee
-$2,644,889
Market Cap
16.00M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9 | 6 | 200.00% |
Jun 30, 2021 | 3 | 1 | 50.00% |
Jun 30, 2020 | 2 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IXHL News
- 25 days ago - Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 7 weeks ago - Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - Newsfile Corp
- 2 months ago - Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - GlobeNewsWire
- 3 months ago - Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - GlobeNewsWire
- 5 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Newsfile Corp
- 5 months ago - Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire